کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2153722 | 1090202 | 2013 | 8 صفحه PDF | دانلود رایگان |
IntroductionWith the aim of developing radiotracers for in vivo positron emission tomography (PET) imaging of solid tumors based on the enhanced permeability and retention effect of nanocarriers, we have developed a polymer micelle named “Lactosome”, which is composed of the amphiphilic polydepsipeptide, poly(L-lactic acid)-block-poly(sarcosine). This paper describes and evaluates the initial evaluation of the 18F-labeled Lactosome as a novel contrast agent for the tumor PET imaging technique carried out.Methods18F-labeled Lactosomes were prepared by a film hydration method under sonication in water at 50 °C from a mixture of 4-[18F]fluoro-benzoyl poly-L-lactic acid (18F-BzPLLA30) and the amphiphilic polydepsipeptide. For biodistribution studies, BALB/cA Jcl-nu/nu mice bearing HeLa cells in the femur region were used. We took both PET and near-infrared fluorescence (NIRF) images of tumor bearing mice after co-injection of 18F-labeled Lactosome and NIRF-labeled Lactosome.Results18F-labeled Lactosomes were prepared at good yields (222–420 MBq) and more than 99% of 18F-BzPLLA30 was incorporated into 18F-labeled Lactosome. The radioactivity of 18F-labeled Lactosome was found to be stable and maintained at high level for up to 6 h after injection into the blood stream. Tumor uptake increased gradually after the injection. The uptake ratio of tumor/muscle was 2.7 at 6 h from the time of injection. Tumor PET imaging with 18F-labeled Lactosome was as capable as tumor NIRF imaging with NIRF-labeled Lactosome.ConclusionTumor PET imaging using Lactosome as a nanocarrier may be therefore a potential candidate for a facile and general solid tumor imaging technique.
Journal: Nuclear Medicine and Biology - Volume 40, Issue 3, April 2013, Pages 387–394